{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:06:14Z","timestamp":1788606374112,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K16569"],"award-info":[{"award-number":["17K16569"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40792-018-0425-4","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T04:39:16Z","timestamp":1518842356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature"],"prefix":"10.1186","volume":"4","author":[{"given":"Tomoko","family":"Yoshimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kanetaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Isagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoe","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhisa","family":"Takatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1245\/s10434-012-2658-y","volume":"20","author":"L Wang","year":"2013","unstructured":"Wang L, Lin Y, Long H, Liu H, Rao H, He Y, et al. Esophageal carcinosarcoma: a unique entity with better prognosis. Ann Surg Oncol. 2013;20:997\u20131004.","journal-title":"Ann Surg Oncol"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10388-016-0556-2","volume":"14","author":"Japan Esophageal Society","year":"2017","unstructured":"Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14:37\u201365.","journal-title":"Esophagus"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/cas.12274","volume":"104","author":"H Hara","year":"2013","unstructured":"Hara H, Tahara M, Daiko H, Kato K, Igaki H, Kadowaki S, et al. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci. 2013;104:1455\u201360.","journal-title":"Cancer Sci"},{"key":"425_CR4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.5858\/2010-0074-RSR.1","volume":"135","author":"MA Raza","year":"2011","unstructured":"Raza MA, Mazzara PF. Sarcomatoid carcinoma of esophagus. Arch Pathol Lab Med. 2011;135:945\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1442-2050.2006.00551.x","volume":"19","author":"Y Sanada","year":"2006","unstructured":"Sanada Y, Hihara J, Yoshida K, Yamaguchi Y. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus. 2006;19:119\u201331.","journal-title":"Dis Esophagus"},{"key":"425_CR6","first-page":"3375","volume":"29","author":"A Sano","year":"2009","unstructured":"Sano A, Sakurai S, Kato H, Sakai M, Tanaka N, Inose T, et al. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma. Anticancer Res. 2009;29:3375\u201380.","journal-title":"Anticancer Res"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1442-2050.2009.00976.x","volume":"23","author":"CJ Kuo","year":"2010","unstructured":"Kuo CJ, Lin TN, Lin CJ, Wu RC, Chang HK, Chu YY, et al. Clinical manifestation of esophageal carcinosarcoma: a Taiwan experience. Dis Esophagus. 2010;23:122\u20137.","journal-title":"Dis Esophagus"},{"key":"425_CR8","first-page":"99","volume":"20","author":"S Iyomasa","year":"1990","unstructured":"Iyomasa S, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Itabashi M. Carcinosarcoma of the esophagus: a twenty-case study. Jpn J Clin Oncol. 1990;20:99\u2013106.","journal-title":"Jpn J Clin Oncol"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3892\/ol.2012.1095","volume":"5","author":"F Xu","year":"2013","unstructured":"Xu F, Zou WB, Li XP, Xu YM, Qi XF, Hu LH, et al. Multiple carcinosarcomas of the esophagus and stomach. Oncol Lett. 2013;5:1017\u201321.","journal-title":"Oncol Lett"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/modpathol.2011.59","volume":"24","author":"CO Sung","year":"2011","unstructured":"Sung CO, Park CK, Kim SH. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod Pathol. 2011;24:1060\u20138.","journal-title":"Mod Pathol"},{"key":"425_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/jclinpath-2012-201271","volume":"66","author":"CO Sung","year":"2013","unstructured":"Sung CO, Choi H, Lee KW, Kim SH. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition. J Clin Pathol. 2013;66:601\u20136.","journal-title":"J Clin Pathol."},{"key":"425_CR12","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/onc.2013.101","volume":"33","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yan W, Chen X. P63 regulates tubular formation via epithelial-to-mesenchymal transition. Oncogene. 2014;33:1548\u201357.","journal-title":"Oncogene"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"key":"425_CR14","first-page":"43","volume":"29","author":"V Ravi","year":"2015","unstructured":"Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park). 2015;29:43\u201350.","journal-title":"Oncology (Williston Park)"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","volume":"17","author":"P Pautier","year":"2012","unstructured":"Pautier P, Floquet A, Penel N, Piperno-Neumann S, Isambert N, Rey A, et al. Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group study (TAXOGEM study). Oncologist. 2012;17:1213\u201320.","journal-title":"Oncologist"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"e0176972","DOI":"10.1371\/journal.pone.0176972","volume":"12","author":"M Takahashi","year":"2017","unstructured":"Takahashi M, Komine K, Imai H, Okada Y, Saijo K, Shirota H, et al. Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: results from a single-institutional analysis. PLoS One. 2017;12:e0176972.","journal-title":"PLoS One"},{"key":"425_CR17","doi-asserted-by":"publisher","unstructured":"Choi Y, Yun MS, Lim SH, Lee J, Ahn JH, Kim YJ, et al. Gemcitabine and docetaxel combination for advanced soft tissue sarcoma: a nationwide retrospective study. Cancer Res Treat. 2017. https:\/\/doi.org\/10.4143\/crt.2016.535 .","DOI":"10.4143\/crt.2016.535"},{"key":"425_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","volume":"109","author":"ML Hensley","year":"2008","unstructured":"Hensley ML, Blessing JA, Mannel R, Rose PG. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008;109:329\u201334.","journal-title":"Gynecol Oncol"},{"key":"425_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygyno.2008.02.024","volume":"109","author":"ML Hensley","year":"2008","unstructured":"Hensley ML, Blessing JA, Degeest K, Abulafia O, Rose PG, Homesley HD. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol. 2008;109:323\u20138.","journal-title":"Gynecol Oncol"},{"key":"425_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13256-015-0719-0","volume":"9","author":"O Maeda","year":"2015","unstructured":"Maeda O, Moritani S, Ichihara S, Inoue T, Ishihara Y, Yamamoto S, et al. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report. J Med Case Rep. 2015;9:233.","journal-title":"J Med Case Rep"},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"425_CR22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/SLA.0b013e3182a6191d","volume":"258","author":"J Shapiro","year":"2013","unstructured":"Shapiro J, ten Kate FJ, van Hagen P, Biermann K, Wijnhoven BP, van Lanschot JJ. Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa. Ann Surg. 2013;258:678\u201388. discussion 88-9","journal-title":"Ann Surg"},{"key":"425_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10388-009-0187-y","volume":"6","author":"T Zuiki","year":"2009","unstructured":"Zuiki T, Hosoya Y, Ui T, Haruta H, Kurashina K, Saito S, et al. Therapeutic effectiveness of chemoradiotherapy for carcinosarcoma of the esophagus: two case reports and a review of the literature. Esophagus. 2009;6:189\u201395.","journal-title":"Esophagus"},{"key":"425_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10388-010-0233-9","volume":"7","author":"D Kobayashi","year":"2010","unstructured":"Kobayashi D, Koike M, Kodera Y, Fujiwara M, Nakayama G, Nakao A. Carcinosarcoma of the esophagus treated with chemoradiotherapy: report of four cases. Esophagus. 2010;7:119\u201325.","journal-title":"Esophagus"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ccr3.295","volume":"3","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi S, Nagata Y, Tokai H, Ito M, Fujioka H. Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case. Clin Case Rep. 2015;3:681\u20135.","journal-title":"Clin Case Rep"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480\u2013508.","journal-title":"J Nucl Med"},{"key":"425_CR27","first-page":"1002","volume":"39","author":"T Fukunaga","year":"1998","unstructured":"Fukunaga T, Okazumi S, Koide Y, Isono K, Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med. 1998;39:1002\u20137.","journal-title":"J Nucl Med"},{"key":"425_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1272\/jnms.81.401","volume":"81","author":"T Matsutani","year":"2014","unstructured":"Matsutani T, Nomura T, Hagiwara N, Yoshida H, Yokoyama T, Katayama H, et al. A case of carcinosarcoma of the esophagus detected on fluorodeoxyglucose positron emission tomography. J Nippon Med Sch. 2014;81:401\u20135.","journal-title":"J Nippon Med Sch"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-018-0425-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0425-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-018-0425-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T13:30:44Z","timestamp":1660483844000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-018-0425-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/s40792-018-0425-4","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The publication of the present study was undertaken in accordance with the ethical standards of our institution (17061947).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient and his family for the publication of this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"18"}}